Growing community of inventors

Naples, Italy

Enrico Abignente

Average Co-Inventor Count = 14.99

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Enrico Abignente ↔ Antonio Calignano (1 patent)Enrico Abignente ↔ Giovanna La Rana (1 patent)Enrico Abignente ↔ Maria Grazia Rimoli (1 patent)Enrico Abignente ↔ Rosario Cuomo (1 patent)Enrico Abignente ↔ Gianpiero Boatto (1 patent)Enrico Abignente ↔ Daniela Melisi (1 patent)Enrico Abignente ↔ Annalisa Curcio (1 patent)Enrico Abignente ↔ Elvira Luongo (1 patent)Enrico Abignente ↔ Oscar Sasso (1 patent)Enrico Abignente ↔ Giovanni Sarnelli (1 patent)Enrico Abignente ↔ Roberto Russo (1 patent)Enrico Abignente ↔ Maria Nieddu (1 patent)Enrico Abignente ↔ Carla Cirillo (1 patent)Enrico Abignente ↔ Salvatore De Lucia (1 patent)Enrico Abignente ↔ Oscar Sasso (0 patent)Enrico Abignente ↔ Roberto Russo (0 patent)Enrico AbignenteEnrico Abignente (1 patent)Antonio CalignanoAntonio Calignano (5 patents)Giovanna La RanaGiovanna La Rana (3 patents)Maria Grazia RimoliMaria Grazia Rimoli (1 patent)Rosario CuomoRosario Cuomo (1 patent)Gianpiero BoattoGianpiero Boatto (1 patent)Daniela MelisiDaniela Melisi (1 patent)Annalisa CurcioAnnalisa Curcio (1 patent)Elvira LuongoElvira Luongo (1 patent)Oscar SassoOscar Sasso (1 patent)Giovanni SarnelliGiovanni Sarnelli (1 patent)Roberto RussoRoberto Russo (1 patent)Maria NiedduMaria Nieddu (1 patent)Carla CirilloCarla Cirillo (1 patent)Salvatore De LuciaSalvatore De Lucia (1 patent)Oscar SassoOscar Sasso (0 patent)Roberto RussoRoberto Russo (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,812 patents)

2. Stewart Italia Srl (1 from 1 patent)

3. Calignano, Antonio (0 patent)

4. Cuomo, Rosario (0 patent)

5. Boatto, Gianpiero (0 patent)

6. Rimoli, Maria Grazia (0 patent)


1 patent:

1. 8551958 - Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…